ANVS: Annovis Bio, Inc. Stock

by  •  • Comments Off on ANVS: Annovis Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 98.43
Enterprise Value ($M) 85.79
Book Value ($M) 7.06
Book Value / Share 0.54
Price / Book 13.93
NCAV ($M) 7.06
NCAV / Share 0.54
Price / NCAV 13.93

Profitability (mra)
Return on Invested Capital (ROIC) -5.80
Return on Assets (ROA) -4.00
Return on Equity (ROE) -6.15

Liquidity (mrq)
Quick Ratio 2.66
Current Ratio 2.66

Balance Sheet (mrq) ($M)
Current Assets 14.36
Assets 14.36
Liabilities 7.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-28 13G/A Hirschman Orin 4.58 -18.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-13 34,089 139,697 24.40
2024-11-12 34,797 164,713 21.13
2024-11-11 91,721 590,594 15.53
2024-11-08 46,112 269,634 17.10

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA
ANRO – Alto Neuroscience, Inc. BHC – Bausch Health Companies Inc.
BHVN – Biohaven Ltd.


Financial data and stock pages provided by
Fintel.io